CTIBIOTECH USA
CTIBIOTECH USA46About
What does CTIBIOTECH USA do?
CTIBIOTECH USA is the newly established North American subsidiary of CTIBIOTECH, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) and a global leader in the 3D bioprinting of human tissue. The company's official introduction took place at the SelectUSA Investment Summit in Washington, D.C. From its new U.S. location, CTIBIOTECH USA aims to expand its operations and offerings in the North American market.
What is CTIBIOTECH USA's revenue?
StartupHub estimates CTIBIOTECH USA's annual revenue at $3.7M (range $2.1M to $9.6M, 69% confidence), based on comparable companies in the sector.
What is CTIBIOTECH USA's valuation?
StartupHub estimates CTIBIOTECH USA's effective valuation at $15.7M (range $10.6M to $25.5M, 23% confidence), based on comparable companies in the sector.
How much funding has CTIBIOTECH USA raised?
CTIBIOTECH USA has raised a total of $4M in funding. The most recent round on record is Undisclosed.
Where is CTIBIOTECH USA headquartered?
CTIBIOTECH USA is headquartered in Philadelphia, Pennsylvania, USA.
When was CTIBIOTECH USA founded?
CTIBIOTECH USA was founded in 2024.
What industry does CTIBIOTECH USA operate in?
CTIBIOTECH USA operates in Biotechnology, Healthcare, 3D Printing, Regenerative Medicine, Biotech, CRDMO.
How many employees does CTIBIOTECH USA have?
CTIBIOTECH USA has approximately 22 people on record.
No comments yet. Be the first to share your take.